Myocardial Ischemia and Transfusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3506 participants.
Also called NCT02981407
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 3,506 participants
- Sponsor
- Registry
-
NCT02981407
-
- Other papers using this trial's data
- Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial
- Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINT
- Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial
- Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data
- Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial
- Effect of age on restrictive and liberal transfusion outcomes in patients with anemia and myocardial infarction
- Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia
- Red Cell Transfusion in Critically Ill and Noncritically Ill Patients With Acute Myocardial Infarction and Anemia-A Subanalysis of the Myocardial Ischemia and Transfusion (MINT) Trial
- Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
- Restrictive vs Liberal Transfusion Strategy After Myocardial Infarction: A Post Hoc Analysis of the MINT Randomized Clinical Trial
- Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Brazil, Canada, France, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT02981407. Randomized; single masking; primary purpose treatment. Start 2017-04-25 (actual); primary completion 2023-05-31 (actual). Results posted on 2024-05-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Myocardial Ischemia and Transfusion
- Acronym
- MINT
- Condition
- Myocardial Infarction
- Condition
- Anemia
- Intervention (Biological)
- Red Blood Cell Transfusion
- Lead sponsor
- Rutgers, The State University of New Jersey
- Collaborator
- University of Pittsburgh
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct02981407- Content hash
b94575098121c8b16cbdcbac306b7d1e80138b20a21dab9803a95042d4c4fbf0